Stay updated with breaking news from Recurrence Score. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that Japan's Ministry of Health, Labor and Welfare (MHLW) has approved the Oncotype DX...
Exact Sciences Announces Fourth Quarter 2020 Results News provided by Share this article Share this article MADISON, Wis., Feb. 16, 2021 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company generated revenue of $466.3 million for the fourth quarter ended Dec. 31, 2020 and $1,491.4 million for the full year ended Dec. 31, 2020. "Exact Sciences finished another transformative year by delivering strong fourth quarter results against a challenging backdrop because of the pandemic," said Kevin Conroy, chairman and CEO of Exact Sciences. "We are a leader in cancer...
Genomic test has lower prognostic accuracy in minority patients with breast cancer Black women have higher recurrence and mortality rates than non-Hispanic white women for certain types of breast cancer, according to a University of Illinois Chicago researcher's study published recently in JAMA Oncology. Dr. Kent Hoskins, associate professor in the UIC College of Medicine's division of hematology/oncology, and co-leader of the Breast Cancer Research group in the University of Illinois Cancer Center, published the study, "Association of race/ethnicity and the 21-gene Recurrence Score with bre...
0 to 10: HR 2.54 (95% CI 1.44-4.50) 11 to 25: HR 1.64 (95% CI 1.23-2.18) >25: HR 1.48 (95% CI 1.10-1.98) "This study suggests that Black women in the U.S. with ER-positive, ERBB2-negative, axillary lymph node-negative breast cancer are more likely to have a high-risk RS [recurrence score] and to experience breast cancer-specific mortality compared with non-Hispanic white women within the same risk group," Hoskins and co-authors wrote. "In addition, the RS provides less prognostic information for Black women." Accuracy of the 21-gene recurrence score was significantly worse for Black women (C...
E-Mail Black women have higher recurrence and mortality rates than non-Hispanic white women for certain types of breast cancer, according to a University of Illinois Chicago researcher's study published recently in JAMA Oncology. Dr. Kent Hoskins, associate professor in the UIC College of Medicine's division of hematology/oncology, and co-leader of the Breast Cancer Research group in the University of Illinois Cancer Center, published the study, "Association of race/ethnicity and the 21-gene Recurrence Score with breast cancer-specific mortality among US women" in the Jan. 21 online issue...